Andrew Lu
Impact in
- Developmental Neuroscience top 10%
- Neurogenesis and neuroplasticity mechanisms
-
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Histone Deacetylase Inhibitors Research 2
- Angiogenesis and VEGF in Cancer 2
- Advanced biosensing and bioanalysis techniques 1
- Signaling Pathways in Disease 1
- Oncology 4
- Cancer-related Molecular Pathways 3
- Cancer Cells and Metastasis 2
- Co-authors
- Yi Lü (4 shared papers)Liyuan Li (3 shared papers)Xin Sun (1 shared paper)Tianyi Li (1 shared paper)Dongming Sun (1 shared paper)Dayanjali Wijesinghe (1 shared paper)Jianqing Fan (1 shared paper)Wise Young (1 shared paper)
- Journals
- Nature Medicine (1 paper)Scientific Reports (1 paper)Cancer Investigation (1 paper)Oncogene (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Andrew Lu
9 papers receiving 376 citations
Peers
Comparison fields: 5 of 64
- Developmental Neuroscience 44
- Neurology 47
- Cancer Research 76
- Cellular and Molecular Neuroscience 81
- Pathology and Forensic Medicine 58
Countries citing papers authored by Andrew Lu
This map shows the geographic impact of Andrew Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Lu more than expected).
Fields of papers citing papers by Andrew Lu
This network shows the impact of papers produced by Andrew Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Lu. The network helps show where Andrew Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 105 | |
| 2 | 2018 | 81 | |
| 3 | 2013 | 44 | |
| 4 | 2017 | 37 | |
| 5 | Suppression of breast cancer metastasis through the inhibition of VEGF-mediated tumor angiogenesis. | 2007 | 32 |
| 6 | 2010 | 29 | |
| 7 | 2018 | 25 | |
| 8 | 2010 | 19 | |
| 9 | 2014 | 5 |
About Andrew Lu
Andrew Lu is a scholar working on Molecular Biology, Oncology, Cancer Research, Cellular and Molecular Neuroscience and Genetics, having authored 9 papers that have together received 377 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer-related Molecular Pathways (3 papers), Nerve injury and regeneration (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Cancer Cells and Metastasis (2 papers), Advanced biosensing and bioanalysis techniques (1 paper) and Signaling Pathways in Disease (1 paper). The work is most often cited by research in Developmental Neuroscience (44 citations), Neurology (47 citations), Cancer Research (76 citations), Cellular and Molecular Neuroscience (81 citations) and Pathology and Forensic Medicine (58 citations). Andrew Lu has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Yi Lü, Liyuan Li, Xin Sun, Tianyi Li, Dongming Sun, Dayanjali Wijesinghe, Jianqing Fan, Wise Young, Xi Wang and Yi Ren. Their work appears in journals such as Nature Medicine, Scientific Reports, Cancer Investigation, Oncogene and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.